Connect with the Toronto Branch Support Group.
Contact Michael Mallinson for more information.
Tel: (416) 694-5493
Cosentyx first Interleukin-17A inhibitor for psoriatic arthritis and ankylosing spondylitis approved by Health CanadaRead
A multifaceted approach for the early clinical identification of axial spondyloarthritis: a study of first degree relativesRead